This review focuses on the expression, regulation and evolution of GPX3 in non-neoplastic diseases, assesses its potential as a prognostic and diagnostic biomarker and explores new therapeutic avenues targeting GPX3. This evidence concerns the gene GPX3 and neoplasm.